AMN Healthcare Reports Q2 2025 Revenue Down 11%, Expects 9-11% YoY Decline in Q3

AMN Healthcare reported Q2 2025 revenue of $658.2 million, an 11% decline YoY, and a net loss of $116.2 million due to $128 million in impairment charges. The company expects a 9-11% revenue decline YoY in Q3 2025 and an adjusted EBITDA margin between 7.7%-8.2%. CEO Cary Grace pointed to enhancements in AI and technology-enabled services as potential growth areas.

AMN Healthcare Services, Inc. (NYSE: AMN), a leading provider of total talent solutions for healthcare organizations, announced its second quarter 2025 financial results. The company reported a revenue of $658.2 million, a 11% decline year-over-year (YoY) [1]. Despite the revenue decrease, the company experienced a net loss of $116.2 million, primarily due to $128 million in impairment charges [1].

Adjusted EBITDA for the quarter was $58.3 million, a 38% drop from the prior year, while adjusted EBITDA margin decreased to 8.9% [1]. The company expects a 9-11% revenue decline YoY in the third quarter 2025, with an adjusted EBITDA margin between 7.7%-8.2% [1].

CEO Cary Grace highlighted the company's advancements in AI and technology-enabled services as potential growth areas, noting that the enhanced capabilities position AMN to gain market share [1].

References:
[1] https://ir.amnhealthcare.com/news-releases/news-release-details/amn-healthcare-announces-second-quarter-2025-results